Alsabti E A, Kamel A
Neoplasma. 1979;26(5):603-9.
Serum carcinoembryonic antigen (CEA) concentration was found to be raised in 503 of 550 patients (91%) with bladder cancer, lymphoma of intestine, hepatocellular carcinoma, bronchogenic carcinoma, prostate cancer, cirrhosis of liver and bilharziasis. The degree of elevation was moderate in all patients except in 189 patients in whom values more than 20 ng/ml were recorded, of which 53 patients with bladder cancer and 118 patients with bilharziasis. The mean CEA value in the patients with cirrhosis in the non-tumorous liver was slightly higher than that in those without cirrhosis, but the difference did not reach statistical significance (P greater than 0.01). There was no correlation between serum CEA and alph-fetoprotein (AFP) levels in all patients except in patients with bladder carcinoma, hepatoma and bilharziasis.
在550例患有膀胱癌、肠道淋巴瘤、肝细胞癌、支气管癌、前列腺癌、肝硬化和血吸虫病的患者中，发现503例（91%）患者的血清癌胚抗原（CEA）浓度升高。除189例患者CEA值超过20 ng/ml外，所有患者的升高程度均为中度，其中53例为膀胱癌患者，118例为血吸虫病患者。非肿瘤性肝脏肝硬化患者的平均CEA值略高于无肝硬化患者，但差异无统计学意义（P>0.01）。除膀胱癌、肝癌和血吸虫病患者外，所有患者的血清CEA与甲胎蛋白（AFP）水平均无相关性。
